New Developments in the Treatment of Neutropenia

American Journal of Diseases of Children

Volumn 147, Issue 9, 1993, Pages 994-1000

  Dunkel, Ira J ^a   Bussel, James B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 3;

AUTOIMMUNITY; CHRONIC DISEASE; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW;

CHILD; CHRONIC DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC CELL GROWTH FACTORS; HIV INFECTIONS; HIV-1; HUMAN; IMMUNOGLOBULINS, INTRAVENOUS; LEUKOCYTE COUNT; NEUTROPENIA; SUPPORT, NON-U.S. GOV'T;

EID: 0027297125     PISSN: 00968994     EISSN: 23742976     Source Type: Journal    
DOI: 10.1001/archpedi.1993.02160330084026     Document Type: Article

References (83)

1. Dale DC, Guerry D, Wewerka JR, Bull JM, Chusid MJ. Chronic neutropenia. Medicine. 1979;58:128-144.
2. Van Der Veen JPW, Hack CE, Engelfriet CP, Pogels JG, Von Dem Borre AEG. Chronic idiopathic and secondary neutropenia: clinical and serological investigations. Br J Haematol. 1986;63:161-171.
3. Curnutte JT, Boxer LA. Disorders of granulopoiesis and granulocyte function. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1987:797-847.
4. Caramihai E, Karayalcin G, Aballi A, Lanzkowsky P. Leukocyte count differences in healthy white and black children 1 to 5 years of age. J Pediatr. 1975;86:252-254.
5. Sadowitz PD, Oski FA. Differences in polymorphonuclear counts between healthy white and black infants: response to meningitis. Pediatrics. 1983;72:405-407.
6. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64:328-340.
7. Yang KD, Hill HR. Neutrophil function disorders: pathophysiology, prevention, and therapy. J Pediatr. 1991;119:343-354.
8. Wright DG, Dale DC, Fauci AS, Wolff SM. Human cyclic neutropenia: clinical review and long-term follow-up of patients. Medicine. 1981;60:1-13.
9. Worthington M. Lack of effect of lithium carbonate on zidovudine-associated neutropenia in patients with AIDS. J Infect Dis. 1990;162:777-778.
10. Mahoney DH, Ambruso DR, McCabe ERB, Anderson DC, Leonard JV, Dunger DB. Lack of effect of lithium carbonate in patients with glycogenosis lb. AJDC. 1987;141:985-986.
11. Metcalf D. Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science. 1991;254:529-533.
12. Grosh WW, Quesenberry PJ. Recombinant human hematopoietic growth factors in the treatment of cytopenias. Clin Immunol Immunopathol. 1992;62:S25-S38.
13. Ganser A, Seipelt G, Lindemann A, et al. Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood. 1990; 76:455-462.
14. Ganser A, Lindemann A, Seipelt G, et al. Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood. 1990;76:666-676.
15. Kurzrock R, Talpaz M, Estrov Z, Rosenblum MG, Gutterman JU. Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. J Clin Oncol. 1991;9:1241-1250.
16. Ganser A, Lindemann A, Seipelt G, et al. Effects of recombinant human interleukin-3 in aplastic anemia. Blood. 1990;76:1287-1292.
17. Lyman SD, Williams DE. Biological activities and potential therapeutic uses of Steel factor. Am J Pediatr Hematol Oncol. 1992;14:1-7.
18. Curtis BM, Williams DE, Broxmeyer HE, et al. Enhanced hematopoietic activity of a human granulocyte-macrophage colony-stimulating factor-interleukin-3 fusion protein. Proc Natl Acad Sci U S A. 1991;88:5809-5813.
19. Perrine SP, Vichinsky E, Faller DV. Hematopoietic hormones: from cloning to clinic. Am J Pediatr Hematol Oncol. 1989;11:268-275.
20. Andreeff M, Welte K. Hematopoietic colony-stimulating factors. Semin Oncol. 1989;16:211-229.
21. Glaspy JA, Golde DW. The colony-stimulating factors: biology and clinical use. Oncology. 1990;4:25-34.
22. Groopman JE, Molina JM, Scadden DT. Hematopoietic growth factors. N Engl J Med. 1989;321:1449-1459.
23. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med. 1992;327: 28-35, 99-106.
24. Kostmann R. Infantile genetic agranulocytosis. Acta Paediatr Scand. 1975;64:362-368.
25. Jonsson OG, Buchanan GR. Chronic neutropenia during childhood. AJDC. 1991;145:232-235.
26. Pietsch T, Buhrer C, Mempel K, et al. Blood mononuclear cells from patients with severe congenital neutropenia are capable of producing granulocyte colony-stimulating factor. Blood. 1991;77:1234-1237.
27. Mempel K, Pietsch T, Menzel T, Zeidler C, Welte K. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood. 1991;77:1919-1922.
28. Glasser L, Duncan BR, Corrigan JJ. Measurement of serum granulocyte colony-stimulating factor in a patient with congenital agranulocytosis (Kostmann's syndrome). AJDC. 1991;145:925-928.
29. Kyas U, Pietsch T, Welte K. Expression of receptors for granulocyte colony-stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia. Blood. 1992;79:1144-1147.
30. Komiyama A, Ishiguro A, Kubo T, et al. Increases in neutrophil counts by purified human urinary colony-stimulating factor in chronic neutropenia of childhood. Blood. 1988;71:41-45.
31. Jakubowski AA, Souza L, Kelly F, et al. Effects of human granulocytic colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med. 1989;320:38-42.
32. Bonilla MA, Gillio AP, Ruggeiro M, et al. Effects of recombinant human granulocytic colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989;320:1574-1580.
33. Weston B, Todd RF, Axtell R, et al. Severe congenital neutropenia: clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor. J Lab Clin Med. 1991;117:282-290.
34. Boxer LA, Hutchinson R, Emerson S. Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia. Clin Immunol Immunopathol. 1992;62:S39-S46.
35. Fazio MT, Glaspy JA. The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia. Oncol Nurs Forum. 1991;18:1411-1414.
36. Welte K, Zeidler C, Reiter A, et al. Differential effects of granulocyte-macrophage colony-stimulating factor in children with severe congenital neutropenia. Blood. 1990;75:1056-1063.
37. Ganser A, Ottman OG, Erdmann H, Schulz G, Hoelzer D. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia. Ann Intern Med. 1989;111:887-892.
38. Daghistani D, Jimenez JJ, Toledano SR, Cirocco RE, Yunis AA. Congenital neutropenia: a case study. Am J Pediatr Hematol Oncol. 1990;12:210-214.
39. Andersson R, Elgefors B, Ridell B, Gisslen M, Kutti J. GM-CSF expands the eosinophilic compartment in chronic idiopathic neutropenia. Eur J Haematol. 1990;44:315-316.
40. Vadhan-Ray S, Jeha SS, Buescher S, et al. Stimulation of myelopoiesis in a patient with congenital neutropenia: biology and nature of response to recombinant human granulocyte-macrophage colony-stimulating factor. Blood. 1990;75:858-864.
41. Kobayashi M, Yumiba C, Kawagushi Y, et al. Abnormal responses of myeloid progenitor cells to recombinant human colony-stimulating factors in congenital neutropenia. Blood. 1990;75:2143-2149.
42. Morley AA. A neutrophil cycle in healthy individuals. Lancet. 1966; 2:1220-1222.
43. Hammond WP, Price TH, Souza LM, Dale DC. Treatment of cyclic neutropenia with granulocytic colony-stimulating factor. N Engl J Med. 1989;320:1306-1311.
44. Hanada T, Ono I, Nagasawa T. Childhood cyclic neutropenia treated with recombinant human granulocyte colony stimulating factor. Br J Haematol. 1990;75:135-137.
45. Sugimoto K, Togawal A, Miyazono K. Treatment of childhood-onset cyclic neutropenia with recombinant human granulocyte colony-stimulating factor. Eur J Haematol. 1990;45:110-111.
46. Freund MRF, Luft S, Schober C, et al. Differential effect of GM-CSF and G-CSF in cyclic neutropenia. Lancet. 1990;336:313.
47. Kurzrock R, Talpaz M, Gutterman JU. Treatment of cyclic neutropenia with very low doses of GM-CSF. Am J Med. 1991;91:317-318.
48. Zon LI, Arkin C, Groopman JE. Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol. 1987;66:251-256.
49. Zon LI, Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol. 1988;25:208-218.
50. McKinney RE, Maha MA, Connor EM, et al. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. N Engl J Med 1991;324:1018-1025.
51. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med. 1991;325:73-80.
52. Groopman JE, Mitsuyasu RT, DeLeo MJ, Oette DH, Golde DW. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med. 1987;317:593-598.
53. Levine JD, Allan JD, Tessitore JH, et al. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. Blood. 1991;78:3148-3154.
54. Kimura S, Matsuda J, Ikematsu S, et al. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. AIDS. 1990;4:1251-1255.
55. Van Der Wouw PA, Van Leeuwen R, Van Oers RHJ, Lange JMA, Danner SA. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study. Br J Haematol. 1991;78:319-324.
56. Schroten H, Wendel U, Burdach S, et al. Colony-stimulating factors for neutropenia in glycogen storage disease lb. Lancet. 1991;337:736-737.
57. Wang WC, Crist WM, Ihle JN, Arnold BA, Keating JP. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type lb. Leukemia. 1991;5:347-349.
58. Schroten H, Roesler J, Breidenbach T, et al. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type lb. J Pediatr. 1991;119:748-754.
59. Weston B, Axtell RA, Todd RF, et al. Clinical and biologic effects of granulocyte colony stimulating factor in the treatment of myelokathexis. J Pediatr. 1991;118:229-234.
60. Hess U, Ganser A, Schnurch HG, et al. Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Br J Haematol. 1992;80:254-256.
61. Wetzler M, Talpaz M, Kellagher MJ, Gutterman JU, Kurzrock R. Myelokathexis: normalization of neutrophil counts and morphology by GM-CSF. JAMA. 1992;267:2179-2180.
62. Russo CL, Glader BE, Israel RJ, Galasso F. Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor. Lancet. 1990;336:751-752.
63. Azuma E, Tabata N, Shibata T, et al. G-CSF enhanced granulocyte production in a child with severe neutropenia in the setting of fatal virus-associated hemophagocytic syndrome. Am J Hematol. 1990;35:266-268.
64. Adachi N, Tsuchiya H, Nunoi H, et al. rhG-CSF for Shwachman's syndrome. Lancet. 1990;336:1136.
65. Laurie AS, Gibson FM, Josten KM, et al. Childhood polyclonal T cell lymphocytosis with neutropenia: effects of antilymphocyte globulin and granulocyte colony stimulating factor in vitro and in vivo. Br J Haematol. 1992;80:446-451.
66. Roberts RL, Szelc CM, Scates SM, et al. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colonystimulating factor. AJDC. 1991;145:808-812.
67. Markusse HM, Breedveld FC, Fibbe WE, Stern AC. Granulocyte-macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome. Arthritis Rheum. 1990;33:1865-1867.
68. Joseph, G, Neustadt DH, Hamm J, Kellihan M, Hadley T. GM-CSF in the treatment of Felty syndrome. Am J Hematol. 1991;37:55-56.
69. Kojima S, Tsuchida M, MatsuyamaT. Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF. N Engl J Med. 1992;326:1294-1295.
70. Lalezari P, Khorshidi M, Petrosova M. Autoimmune neutropenia of infancy. J Pediatr. 1986;109:764-769.
71. Bux J, Mueller-Eckhardt C. Autoimmune neutropenia. Semin Hematol. 1992;29:45-53.
72. Conway LT, Clay ME, Kline WE, Ramsay NKC, Krivit W, McCullough J. Natural history of primary autoimmune neutropenia in infancy. Pediatrics. 1987;79:728-733.
73. Ducos R, Madyastha PR, Warrier RP, Glassman AB, Shirley LR. Neutrophil agglutinins in idiopathic chronic neutropenia of early childhood. AJDC. 1986;140:65-68.
74. Boxer LA, Greenberg MS, Boxer GJ, Stossel TP. Autoimmune neutropenia. N Engl J Med. 1975;293:748-753.
75. Collins PW, Newland AC. Treatment modalities of autoimmune blood disorders. Semin Hematol. 1992;29:64-74.
76. Bussel J, Lalezari P, Fikrig S. Intravenous treatment with gamma-globulin of autoimmune neutropenia of infancy. J Pediatr. 1988;112:298-301.
77. Bussel JB, Lalezari P, Hilgartner M,et al. Reversal of neutropenia with intravenous gamma-globulin in autoimmune neutropenia of infancy. Blood. 1983;62:398-400.
78. Hilgartner MW, Bussel J. Use of intravenous gamma globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia. Am J Med. 1987;83(4A):25-29.
79. Kurtzberg J, Friedman HS, Chaffee S, et al. Efficacy of intravenous gamma globulin in autoimmune-mediated pediatric blood dyscrasias. Am J Med. 1987;83(4A):4-9.
80. Gordon BG, Kiwanuka J, Kadushin J. Autoimmune neutropenia and Hodgkin's disease: successful treatment with intravenous gammaglobulin. Am J Pediatr Hematol Oncol. 1991;13:164-167.
81. Levine DH, Madyastha PR. Isoimmune neonatal neutropenia. Am J Perinatol. 1986;3:231-233.
82. Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med. 1991;325:110-117.
83. Ben-Chetrit E, Putterman C. Transient neutropenia induced by intravenous immune globulin. N Engl J Med. 1992;326:270-271.